Xinyu Luo Selected Research

Xinyu Luo Research Topics

5	Neoplasms (Cancer) 04/2024 - 01/2022
3	Infections 12/2023 - 11/2021
2	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2023
2	Leukemia 12/2023 - 06/2023
2	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2020
1	Inflammation (Inflammations) 04/2024
1	Sepsis (Septicemia) 12/2023
1	Periodontal Diseases (Periodontal Disease) 11/2023
1	Tooth Loss 11/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2023
1	Skin Diseases (Skin Disease) 10/2023
1	Nervous System Diseases (Neurological Disorders) 10/2023
1	Lung Neoplasms (Lung Cancer) 09/2023
1	Disease Progression 09/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2023
1	Body Weight (Weight, Body) 06/2023
1	Glioma (Gliomas) 12/2022
1	Cardiac Arrhythmias (Arrythmia) 09/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Pathologic Complete Response 01/2020
1	Stomach Neoplasms (Stomach Cancer) 04/2018

4	Biomarkers (Surrogate Marker)IBA 09/2023 - 04/2018
3	elemeneIBA 12/2023 - 12/2022
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2023 - 12/2022
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
1	Messenger RNA (mRNA)IBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	lenvatinibIBA 04/2024
1	AntigensIBA 01/2024
1	Chimeric Antigen ReceptorsIBA 01/2024
1	Vancomycin FDA LinkGeneric 12/2023
1	2- (4- ((3,4- dichloro- 5- methyl- 1H- pyrrole- 2- carbonyl)amino)- 3- methoxy- 1- piperidyl)- 4- ((2- methoxy- 1- methylethyl)carbamoyl)thiazole- 5- carboxylic acidIBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	pertuzumabIBA 10/2023
1	Trastuzumab (Herceptin)FDA Link 10/2023
1	camrelizumabIBA 09/2023
1	Nitric Oxide DonorsIBA 06/2023
1	TetracyclinesIBA 01/2023
1	QuercetinIBA 01/2023
1	CholesterolIBA 01/2022
1	AcyltransferasesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	SterolsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Drinking WaterIBA 11/2021
1	Long Noncoding RNAIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 04/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2018

4	Drug Therapy (Chemotherapy) 10/2023 - 01/2022
3	Therapeutics 01/2024 - 01/2022
2	Immunotherapy 09/2023 - 01/2022
1	Oral Medicine 11/2023
1	Aftercare (After-Treatment) 06/2023
1	Radiotherapy 01/2022
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2021
1	Neoadjuvant Therapy 01/2020